| Number (n = 209) | Percent |
---|---|---|
ER/PR status | ||
 ER-positive | 163 | 78.0 |
 ER-negative | 40 | 19.1 |
 PR-positive | 120 | 57.4 |
 PR-negative | 83 | 39.7 |
 ER-positive and PR-positive | 117 | 56.0 |
 ER-positive and PR-negative | 46 | 22.0 |
 ER-negative and PR-negative | 37 | 17.7 |
 Unknown | 6 | 2.9 |
HER2 status | ||
 HER2-positive | 59 | 28.2 |
 HER2-negative | 140 | 67.0 |
 Intermediate | 1 | 0.5 |
 Unknown | 9 | 4.3 |
Lymph node status | ||
 LN-positive | 75 | 35.9 |
 LN-negative | 111 | 53.1 |
 Unknown | 23 | 11.0 |
Grade | ||
 1 | 34 | 16.3 |
 2 | 96 | 45.9 |
 3 | 66 | 31.6 |
 Unknown | 13 | 6.2 |
Tumor type | ||
 Invasive ductal carcinoma | 168 | 80.4 |
 Invasive lobular carcinoma | 21 | 10.0 |
 DCIS | 2 | 1.0 |
 Other | 14 | 6.7 |
 Unknown | 4 | 1.9 |
Tumor volume | ||
 <10 cm3 | 64 | 30.6 |
 ≥10, <20 cm3 | 48 | 23.0 |
 >20 cm3 | 68 | 32.5 |
 Unknown | 29 | 13.9 |